ARTICLES
Apogenix receives grant to commence phase II trial
January 9, 2012
Pfizer initiates phase I trial for Hemophilia drug
January 9, 2012
Gene Security Network changes name to Natera
January 9, 2012
Circadian launches phase I cancer trial
January 9, 2012
Upcoming Events
-
21Oct